An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the Env precursor interferes with membrane fusion at a Post-CD4 binding step

Virology

Volumn 273, Issue 1, 2000, Pages 169-177

  Barbouche, Rym ^a   Decroly, Etienne ^b   Kieny, Marie Paule ^c   Fenouillet, Emmanuel ^a  

^a CNRS   (France)

^b Inst Natl S de la Rech M   (France)

^c Inst Natl S/Rech M EP99 08   (France)

Author keywords

Anti HIV peptide; Cleavage sequence; HIV Env; Membrane fusion; Processing

Indexed keywords

CD4 ANTIGEN; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; MEMBRANE PROTEIN; PEPTIDE;

ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROCESSING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; RNA VIRUSES;

EID: 0034691603     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0368     Document Type: Article

References (33)

1. Ashorn P., Berger E. A., Moss B. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4. Methods Enzymol. 221:1993;12-18.
2. Avril L. E., Di Martino-Ferrer M., Pignede G., Seman M., Gauthier F. Identification of the U937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G. FEBS Lett. 345:1994;81-86.
3. Barbouche R., Sabatier J. M., Fenouillet E. An anti-HIV peptide construct derived from the cleavage region of Env acts on Env fusogenicity through the presence of a functional cleavage sequence. Virology. 247:1998a;137-143.
4. Barbouche R., Miquelis R., Sabatier J. M., Fenouillet E. SPC3, an anti-HIV peptide construct derived from the viral envelope, binds and enters HIV target cells. J. Peptide Sci. 4:1998b;479-485.
5. Barbouche R., Papandréou M. J., Miquelis R., Guieu R., Fenouillet E. Relationships between the anti-HIV V3-derived peptide SPC3, and lymphocyte membrane properties involved in virus entry: SPC3 interferes with CXCR4. FEMS Microbiol. Lett. 183:2000;235-240.
6. Bosch V., Pawlita M. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J. Virol. 64:1990;2337-2344.
7. Broder C. C., Collman R. G. Chemokine receptors and HIV. J. Leukoc. Biol. 62:1997;20-29.
8. + cells by HIV types 1 and 2 and by SIV. Virology. 181:1991;703-715.
9. Decroly E., Vandenbranden M., Ruysschaert J. M., Cogniaux J., Jacob G. M., Howard S., Marshall G., Kompelli A., Basak A., Jean F. C, Lazure C., Benjannet S., Chrétien M., Day R., Seidah N. The convertase furin and PC1 can both cleave the human immunodeficiency virus type 1 envelope glycoprotein gp160 into gp120 and gp41. J. Biol. Chem. 269:1994;12240-12247.
10. + cell lines. J. Biol. Chem. 271:1996;30442-30450.
11. Doms R. W., Peipert S. C. Unwelcomed guests with master keys: How HIV uses chemokine receptors for cellular entry. Virology. 235:1997;179-190.
12. Dubay J., Dubay S., Hunter E. Analysis of the cleavage of the human immunodeficiency virus type 1 glycoprotein. J. Virol. 69:1995;4675-4682.
13. Einfeld D. Maturation and assembly of retroviral glycoproteins. Curr. Top. Microbiol. 214:1996;133-176.
14. Fenouillet E., Gluckman J. C. Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage. Virology. 187:1992;825-828.
15. Fenouillet E., Jones I. M., Powell B., Schmitt D., Kiény M. P., Gluckman J. C. Functional role of the glycan cluster of the human immunodeficiency virus type 1 transmembrane glycoprotein domain. J. Virol. 67:1993;150-160.
16. Fenouillet E., Papandréou M. J., Jones I. M. Recombinant HIV envelope expressed in an alpha glucosidase I deficient CHO cell line and its parental cell line in the presence of deoxynojirimycin is functional. Virology. 231:1997;89-95.
17. Freed E., Myers D., Risser R. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein gp160. J. Virol. 63:1989;4670-4675.
18. Hallenberger S., Bosch V., Angliker H., Shaw E., Klenk H. D., Garten W. Inhibition of furin mediated cleavage activation of human immunodeficiency virus type 1 glycoprotein gp160. Nature. 360:1992;358-361.
19. Jean F., Basak A., Rondeau N., Benjannet S., Hendy G. N., Seidah N. G., Chrétien M., Lazure C. Enzymic characterization of murine and human prohormone convertase-1 (mPC1 and hPC1) expressed in mammalian GH4C1 cells. Biochem. J. 292:1993;891-900.
20. + lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp120. FEBS Lett. 286:1991;233-236.
21. Kieny M. P., Lathe R., Rivière Y., Dott K., Schmitt D., Girard M., Montagnier L., Lecocq J. P. Improved antigenicity of the HIV env protein by cleavage site removal. Prot. Eng. 2:1988;219-225.
22. Klimstra W. B., Heidner H. W., Johnston R. E. The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate. J. Virol. 73:1999;6299-6306.
23. Lavi E., Strizki J. M., Ulrich A. M., Zhang W., Fu L., Wang Q., O'Connor M., Hoxie J. A., Gonzalez-Scarano F. CXCR-4, a co-receptor for the type 1 human immunodeficiency virus, is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol. 151:1997;1035-1042.
24. Li Z., Sergel T., Razvi E., Morrison T. Effect of cleavage mutants on syncytium formation directed by the wild-type fusion protein of Newcastle disease virus. J. Virol. 72:1998;3789-3795.
25. McCune J., Rabin L. B., Feinberg M. B., Lieberman M., Kosek J. C., Reyes G. R., Weissman I. L. Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus type 1. Cell. 53:1989;55-67.
26. McDougall J. S., Nicholson K. K., Cross D., Cort S. P., Kennedy M. S., Mawle A. C. Binding of the human retrovirus HTLVIII/LAV to the CD4 (T4) molecule. J. Immunol. 137:1986;2937-2944.
27. Mondor I., Ugolini S., Sattentau Q. Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans. J. Virol. 72:1988;3623-3634.
28. Moore J. P., Wiley R. L., Lewis G. K., Robinson J., Sodroski J. Immunological evidence for interactions between C1, C2 and C5 domains of gp120 surface glycoprotein of human immunodeficiency virus type 1. J. Virol. 68:1994;6836-6847.
29. Pfeiffer T., Zentgraf H., Freyaldenhoven B., Bosch V. Transfer of endoplasmic reticulum and Golgi retention signals to human immunodeficiency virus type 1 gp160 inhibits intracellular transport and proteolytic processing of viral glycoprotein but does not influence the cellular site of virus particle budding. J. Gen. Virol. 78:1997;1745-1753.
30. Sabatier J. M., Moulard M., Rochat H., Van Rietschoten J., Fenouillet E. Anti-HIV activity of multibranched peptide constructs derived either from the cleavage sequence or from the transmembrane domain of the human immunodeficiency virus type 1 envelope. Virology. 223:1996;406-408.
31. Steinhauer D. A. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology. 258:1999;1-20.
32. Sugiura W., Broder C., Moss B., Earl P. Characterization of conformation-dependent anti-gp120 murine monoclonal antibodies produced by immunization with oligomeric and monomeric human immunodeficiency virus type 1 envelope proteins. Virology. 254:1999;257-267.
33. Verrier F. C., Charneau P., Altmeyer R., Laurent S., Borman A. M., Girard M. Antibodies to several conformation-dependent epitopes of gp120/gp41 inhibit CCR-5-dependent cell-to-cell fusion mediated by the native envelope glycoprotein of a primary macrophage-tropic HIV-1 isolate. Proc. Natl. Acad. Sci. USA. 94:1997;9326-9331.